Fermac Bio Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 15.00 Cr
as on 16-11-2024
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 44.80 Cr
as on 16-11-2024
About Fermac Bio
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 15.00 Cr.
The company currently has active open charges totaling ₹44.80 Cr.
The Key Managerial Personnel (KMP) at Fermac Bio Private Limited India is Suneel Battula as CEO. Valiveti Brahmaji, Shivakumar Balakrishnan, Jeyamuruga Manoharan, and Three other members serve as directors at the Company.
- CIN/LLPIN
U73100TG2022PTC159954
- Company No.
159954
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Fermac Bio?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suneel Battula | CEO | 14-May-2022 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suneel Battula  | Whole-Time Director | 14-May-2022 | Current |
Valiveti Brahmaji  | Director | 21-Mar-2022 | Current |
| Shivakumar Balakrishnan | Director | 18-Aug-2023 | Current |
| Jeyamuruga Manoharan | Director | 21-Mar-2022 | Current |
| Nithyagovind | Director | 08-Feb-2024 | Current |
Sai Gunda  | Director | 14-May-2022 | Current |
Financial of Fermac Bio.
Fermac Bio Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Fermac Bio?
In 2023, Fermac Bio had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Scires Technologies Private LimitedActive 3 years 10 monthsShivakumar Balakrishnan and Jeyamuruga Manoharan are mutual person
Indian Institute Of Cancer And Research Private LimitedActive 17 years 7 monthsValiveti Brahmaji is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Mar 2023 | ₹22.40 Cr | Open |
Others Creation Date: 17 Sep 2022 | ₹22.40 Cr | Open |
How Many Employees Work at Fermac Bio?
Fermac Bio has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fermac Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fermac Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
